References
- Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clinicians 2011;61:212–236.
- Jaffe ES, Harris NL, Stein H, Vardiman JV, editors. World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001.
- National Comprehensive Cancer Network Database [Internet]. Philadelphia. NCCN Guidelines for Treatment of Cancer by Site; 2015 [cited 2015 Dec 27]. Available from: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site/
- Halm EA, Lee C, Chassin MR. Is volume related to outcome in health care? A systematic review and methodologic critique of the literature. Ann Intern Med. 2002;137:511–520.
- Go RS, Bottner WA, Gertz MA. Making the case to study the volume-outcome relationship in hematologic cancers. Mayo Clinic Proc. 2015;90:1393–1399.
- Hewitt ME, Pettiti DB, editors. National Cancer Policy Board (U.S.), National Research Council (U.S.), Division on Earth and Life Studies. Interpreting the volume-outcome relationship in the context of cancer care. Washington (DC): National Academy Press; 2001.
- Kirkwood MK, Kosty MP, Bajorin DF, et al. Tracking the workforce: the American Society of Clinical Oncology workforce information system. J Oncol Pract. 2013;9:3–8.
- Mehta J, Wang H, Iqbal SU, et al. Epidemiology of myeloproliferative neoplasms in the United States. Leuk Lymphoma 2014;55:595–600.
- Forte GJ, Hanley A, Hagerty K, et al. American Society of Clinical Oncology National Census of Oncology Practices: preliminary report. J Oncol Pract. 2013;9:9–19.
- Al-Hamadani M, Habermann TM, Cerhan JR, et al. Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: a longitudinal analysis of the National Cancer Data Base from 1998 to 2011. Am J Hematol. 2015;90:790–795.
- Al-Hamadani M, Hashmi SK, Go RS. Use of autologous hematopoietic cell transplantation as initial therapy in multiple myeloma and the impact of socio-geo-demographic factors in the era of novel agents. Am J Hematol. 2014;89:825–830.